Deep Genomics is a multidisciplinary team of AI and biology scientists dedicated to pioneering a new era of genomic research and development through BigRNA, the first AI foundation model for decoding RNA biology and designing therapeutics. Founded in 2015, Deep Genomics is at the forefront of revolutionizing drug discovery and development by leveraging cutting-edge AI technologies and biological insights. Through its innovative approach and collaborative partnerships, Deep Genomics aims to accelerate the delivery of life-saving therapeutics to patients worldwide. Deep Genomics is located in Toronto, Ontario, and Cambridge, Massachusetts. For more information, visit: www.deepgenomics.com.